Literature DB >> 24835109

The effect of formalizing enhanced recovery after esophagectomy with a protocol.

J M Findlay1, E Tustian1, J Millo2, A Klucniks2, B Sgromo1, R E K Marshall1, R S Gillies1, M R Middleton3, N D Maynard1.   

Abstract

Enhanced recovery after surgery (ERAS) pathways aim to accelerate functional return and discharge from hospital. They have proven effective in many forms of surgery, most notably colorectal. However, experience in esophagectomy has been limited. A recent study reported significant reductions in pulmonary complications, mortality, and length of stay following the introduction of an ERAS protocol alone, without the introduction of any clinical changes. We instituted a similar change 16 months ago, introducing a protocol to provide a formal framework, for our existing postoperative care. This retrospective analysis compared outcome following esophagectomy for the 16 months before and 20 months after this change. Data were collected from prospectively maintained secure web-based multidisciplinary databases. Complication severity was classified using the Clavien-Dindo scale. Operative mortality was defined as death within 30 days of surgery, or at any point during the same hospital admission. Lower respiratory tract infection was defined as clinical evidence of infection, with or without radiological signs. Respiratory complications included lower respiratory tract infection, pleural effusion (irrespective of drainage), pulmonary collapse, and pneumothorax. Statistical analysis was performed using SPSS v21. One hundred thirty-two patients underwent esophagectomy (55 protocol group; 77 before). All were performed open. There were no differences between the two groups in terms of age, gender, operation, use of neoadjuvant therapy, cell type, stage, tumor site, or American Society of Anesthesiologists grade. Median length of stay was 14.0 days (protocol) compared with 12.0 before (interquartile range 9-19 and 9.5-15.5, respectively; P = 0.073, Mann-Whitney U-test). Readmission within 30 days of discharge occurred in five (9.26%) and six (8.19%; P = 1.000, Fisher's exact test). There were four in-hospital deaths (3.03%): one (1.82%) and three (3.90%), respectively (P = 0.641). There were no differences in the severity of complications (P = non-significant; Pearson's chi-squared). There were no differences in the type of complications occurring in either group. The protocol was completed successfully by 26 (47.3%). No baseline factors were predictive of this. In contrast to previous studies, we did not demonstrate any improvement in outcome by formalizing our existing pathway using a written protocol. Consequently, improvements in short-term outcome from esophagectomy within ERAS would seem to be primarily due to improvements in components of perioperative care. Consequently, we would recommend that centers introducing new (or reviewing existing) ERAS pathways for esophagectomy focus on optimizing clinical aspects of such standardized pathways.
© 2014 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  clinical; esophagectomy; perioperative care; postoperative complication; postoperative period; protocol

Mesh:

Year:  2014        PMID: 24835109     DOI: 10.1111/dote.12234

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  14 in total

1.  Impact of enhanced recovery program on patients with esophageal cancer in comparison with traditional care.

Authors:  Lihong Wang; Chenjing Zhu; Xuelei Ma; Kai Shen; Hongmei Li; Yuanyuan Hu; Linghong Guo; Jing Zhang; Ping Li
Journal:  Support Care Cancer       Date:  2016-10-10       Impact factor: 3.603

2.  An investigation into the nutritional status of patients receiving an Enhanced Recovery After Surgery (ERAS) protocol versus standard care following Oesophagectomy.

Authors:  Katie Benton; Iain Thomson; Elisabeth Isenring; B Mark Smithers; Ekta Agarwal
Journal:  Support Care Cancer       Date:  2018-01-24       Impact factor: 3.603

3.  Expedite recovery from esophagectomy and reconstruction for esophageal squamous cell carcinoma after perioperative management protocol reinvention.

Authors:  Yu-Wei Liu; Fan-Wei Yan; Dong-Lin Tsai; Hsien-Pin Li; Yen-Lung Lee; Hung-Hsing Chiang; Hung-Te Hsu; Hung-Yi Chuang; Shah-Hwa Chou
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 4.  Enhanced recovery protocols after oesophagectomy.

Authors:  Laura J Halliday; Sheraz R Markar; Sophie L F Doran; Krishna Moorthy
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

5.  A successful clinical pathway protocol for minimally invasive esophagectomy.

Authors:  Robert E Merritt; Peter J Kneuertz; Desmond M D'Souza; Kyle A Perry
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584

6.  The effect of enhanced recovery after minimally invasive esophagectomy: a randomized controlled trial.

Authors:  Yaxing Shen; Xiaosang Chen; Junyi Hou; Youwen Chen; Yong Fang; Zhanggang Xue; Xavier Benoit D'Journo; Robert J Cerfolio; Hiran C Fernando; Alfonso Fiorelli; Alessandro Brunelli; Jing Cang; Lijie Tan; Hao Wang
Journal:  Surg Endosc       Date:  2022-06-30       Impact factor: 4.584

7.  Cost-Benefit Analysis of the Implementation of an Enhanced Recovery Program in Liver Surgery.

Authors:  Gaëtan-Romain Joliat; Ismaïl Labgaa; Martin Hübner; Catherine Blanc; Anne-Claude Griesser; Markus Schäfer; Nicolas Demartines
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

8.  Short-term outcomes after conventional transthoracic esophagectomy.

Authors:  Yukiko Niwa; Masahiko Koike; Masashi Hattori; Naoki Iwata; Hideki Takami; Masamichi Hayashi; Mitsuro Kanda; Daisuke Kobayashi; Chie Tanaka; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Shuji Nomoto; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Nagoya J Med Sci       Date:  2016-02       Impact factor: 1.131

9.  Enhanced Recovery after Surgery in a Single High-Volume Surgical Oncology Unit: Details Matter.

Authors:  Timothy L Fitzgerald; Catalina Mosquera; Nicholas J Koutlas; Nasreen A Vohra; Kimberly V Edwards; Emmanuel E Zervos
Journal:  Surg Res Pract       Date:  2016-08-25

Review 10.  A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.

Authors:  J M Findlay; M R Middleton; I Tomlinson
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.